University of Sao Paulo
São Paulo, 05508-030, Brazil
NCT Number: NCT03907059
Dietary protein consumption maximizes the anabolic response during resistance training (RT) by triggering muscle protein synthesis and providing the indispensable amino acids for a net positive protein balance. Leucine is considered the key amino acid in this process, suggesting that differences in protein quality may influence RT-induced gains in muscle mass and strength. In general, plant-based protein sources have lower leucine concentrations than animal-based protein sources and human skeletal muscle. In this respect, despite acute evidence on lower anabolic properties of plant- vs. animal-based protein, the effects of an exclusive plant-based dietary protein diet on RT-induced adaptations are currently unknown.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
São Paulo, 05508-030, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
supplementation individually adjusted to 1.6g/kg/day
supplementation individually adjusted to 1.6g/kg/day
Time frame: 12 weeks
assessed by mode-B ultrasound
Time frame: 12 weeks
assessed by leg-press one-maximum-repetition
Time frame: 12 weeks
assessed by Dual-energy X-ray absorptiometry
Time frame: 12 weeks
assessed by muscle biopsy (vastus lateralis)
University of Sao Paulo
Other
Does Exclusive Consumption of Plant-based Dietary Protein Impair Resistance Training-induced Muscle Adaptations?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03983070
Healthy, Hypertrophy
Buies Creek, North Carolina, United States
View Trial DetailsNCT03678857
Healthy, Hypertrophy
Brandon, Manitoba, Canada
View Trial DetailsNCT00001632
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Bethesda, Maryland, United States
View Trial DetailsNCT06573086
Atrophy, Exercise Training
Jyväskylä, Central Finland, Finland
View Trial Details